pfeiffer syndrome |
Disease ID | 358 |
---|---|
Disease | pfeiffer syndrome |
Definition | An autosomal dominant inherited type of acrocephalosyndactyly caused by mutations in the FGFR1 or FGFR2 genes. It is characterized by early closure of the sutures between the skull bones, bulging and wide-set eyes, broad thumbs, big toes, and partial syndactyly in the hands and toes. |
Synonym | acrocephalosyndactylies, type v acrocephalosyndactyly type v acrocephalosyndactyly type v (disorder) acrocephalosyndactyly, type v acs v acs5 craniofacial-skeletal-dermatologic dysplasia noack syndrome noack syndromes oto-onychoperoneal syndrome pfeiffer syndrome (disorder) pfeiffer syndrome - oto-onychoperoneal pfeiffer's syndrome pfeiffer-type acrocephalosyndactyly pfeiffers syndrome syndrome, noack syndrome, pfeiffer syndromes, noack type v acrocephalosyndactylies type v acrocephalosyndactyly |
Orphanet | |
OMIM | |
DOID | |
UMLS | C0220658 |
SNOMED-CT | |
Curated Gene | Entrez_id | Symbol | Resource(Total Genes:3) |
Inferring Gene | Entrez_id | Symbol | Resource(Total Genes:1) |
Text Mined Gene | Entrez_id | Symbol | Score | Resource(Total Genes:24) 2249 | FGF4 | DISEASES 1947 | EFNB1 | DISEASES 6678 | SPARC | DISEASES 4488 | MSX2 | DISEASES 7291 | TWIST1 | DISEASES 6662 | SOX9 | DISEASES 2247 | FGF2 | DISEASES 2255 | FGF10 | DISEASES 2252 | FGF7 | DISEASES 1513 | CTSK | DISEASES 51715 | RAB23 | DISEASES 2253 | FGF8 | DISEASES 2261 | FGFR3 | DISEASES 112476 | PRRT2 | DISEASES 4534 | MTM1 | DISEASES 2258 | FGF13 | DISEASES 860 | RUNX2 | DISEASES 1280 | COL2A1 | DISEASES 2254 | FGF9 | DISEASES 4487 | MSX1 | DISEASES 7441 | VPREB1 | DISEASES 2260 | FGFR1 | DISEASES 2263 | FGFR2 | DISEASES 2317 | FLNB | DISEASES |
Locus | (Waiting for update.) |
Disease ID | 358 |
---|---|
Disease | pfeiffer syndrome |
Integrated Phenotype | HPO | Name(Total Integrated Phenotypes:22) HP:0001385 | Hip dysplasia HP:0000470 | Short neck HP:0003307 | Hyperlordosis HP:0000194 | Open mouth HP:0000262 | Turricephaly HP:0006101 | Finger syndactyly HP:0004322 | Short stature HP:0001156 | Brachydactyly syndrome HP:0011304 | Broad thumb HP:0000324 | Facial asymmetry HP:0005048 | Synostosis of carpal bones HP:0004209 | Clinodactyly of the 5th finger HP:0000508 | Ptosis HP:0000431 | Wide nasal bridge HP:0000316 | Hypertelorism HP:0000348 | High forehead HP:0012368 | Flat face HP:0010669 | Cheekbone underdevelopment HP:0000322 | Short philtrum HP:0000303 | Mandibular prognathia HP:0000218 | High palate HP:0009773 | Symphalangism affecting the phalanges of the hand |
Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:5) |
Disease ID | 358 |
---|---|
Disease | pfeiffer syndrome |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:22) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs121909627 | 10942429 | 2260 | FGFR1 | umls:C0220658 | BeFree | These studies provide direct genetic evidence that the Pro252Arg mutation in FGFR1 causes human Pfeiffer syndrome and uncovers a molecular mechanism in which Fgf/Fgfr1 signals regulate intramembraneous bone formation by modulating Cbfa1 expression. | 0.20434307 | 2000 | FGFR1 | 8 | 38424690 | G | C |
rs121909627 | 10861678 | 2260 | FGFR1 | umls:C0220658 | BeFree | Molecular analysis of her fibroblast growth factor receptor 1 gene (FGFR1) identified a heterozygous P252R missense mutation, previously only reported with FGFR1-Pfeiffer syndrome like manifestations. | 0.20434307 | 2000 | FGFR1 | 8 | 38424690 | G | C |
rs121909627 | 25251565 | 2260 | FGFR1 | umls:C0220658 | BeFree | Variable expressivity of pfeiffer syndrome in a family with FGFR1 p.Pro252Arg mutation. | 0.20434307 | 2014 | FGFR1 | 8 | 38424690 | G | C |
rs121909627 | 11596961 | 2261 | FGFR3 | umls:C0220658 | BeFree | In this paper the expression of FGFR1, the IgIIIa/c and IgIIIa/b isoforms of FGFR2, and FGFR3 is investigated in Apert syndrome (P253R mutation)- and Pfeiffer syndrome (C278F mutation)-affected fetal cranial tissue and is contrasted with healthy human control tissues. | 0.001085767 | 2001 | FGFR1 | 8 | 38424690 | G | C |
rs121909627 | 11596961 | 2260 | FGFR1 | umls:C0220658 | BeFree | In this paper the expression of FGFR1, the IgIIIa/c and IgIIIa/b isoforms of FGFR2, and FGFR3 is investigated in Apert syndrome (P253R mutation)- and Pfeiffer syndrome (C278F mutation)-affected fetal cranial tissue and is contrasted with healthy human control tissues. | 0.20434307 | 2001 | FGFR1 | 8 | 38424690 | G | C |
rs121909627 | 14564217 | 2260 | FGFR1 | umls:C0220658 | BeFree | We report four new affected families showing an FGFR1 P252R mutation and emphasize the characteristic malformations of the feet in this form of Pfeiffer syndrome. | 0.20434307 | 2003 | FGFR1 | 8 | 38424690 | G | C |
rs121918488 | 10329600 | 2263 | FGFR2 | umls:C0220658 | BeFree | We analyzed cell proliferation and differentiation in osteoblasts obtained from patients with three genetically and clinically distinct craniosynostoses: Pfeiffer syndrome carrying the FGFR2 C342R substitution, Apert syndrome with FGFR2 P253R change, and a nonsyndromic craniosynostosis without FGFR canonic mutations, as compared with control osteoblasts. | 0.331867498 | 1999 | FGFR2 | 10 | 121517379 | A | T,G |
rs121918495 | 9780920 | 2263 | FGFR2 | umls:C0220658 | BeFree | Gene analysis of these patients showed a T341P mutation in the FGFR2 gene in the patient with Pfeiffer syndrome, and a G380R mutation in the FGFR3 gene in the patient with achondroplasia. | 0.331867498 | 1998 | FGFR2 | 10 | 121517382 | T | G |
rs121918497 | 19066959 | 2263 | FGFR2 | umls:C0220658 | BeFree | Q289P mutation in the FGFR2 gene: first report in a patient with type 1 Pfeiffer syndrome. | 0.331867498 | 2009 | FGFR2 | 10 | 121520052 | T | G |
rs121918499 | 24036790 | 2263 | FGFR2 | umls:C0220658 | BeFree | However, her Trp290Cys FGFR2 mutation is reported to be associated with PS type II that includes kleeblatschädel (or cloverleaf) skull anomalies as a cardinal feature. | 0.331867498 | 2014 | FGFR2 | 10 | 121520048 | C | G,A |
rs121918499 | 9150725 | 2263 | FGFR2 | umls:C0220658 | BeFree | Trp290Cys mutation in exon IIIa of the fibroblast growth factor receptor 2 (FGFR2) gene is associated with Pfeiffer syndrome. | 0.331867498 | 1997 | FGFR2 | 10 | 121520048 | C | G,A |
rs121918499 | 18618990 | 2263 | FGFR2 | umls:C0220658 | BeFree | Craniosynostosis and congenital tracheal anomalies in an infant with Pfeiffer syndrome carrying the W290C FGFR2 mutation. | 0.331867498 | 2008 | FGFR2 | 10 | 121520048 | C | G,A |
rs121918499 | NA | 2263 | FGFR2 | umls:C0220658 | CLINVAR | NA | 0.331867498 | NA | FGFR2 | 10 | 121520048 | C | G,A |
rs121918502 | 9714439 | 2263 | FGFR2 | umls:C0220658 | BeFree | Phenotype of the fibroblast growth factor receptor 2 Ser351Cys mutation: Pfeiffer syndrome type III. | 0.331867498 | 1998 | FGFR2 | 10 | 121517351 | G | C |
rs28931614 | 9780920 | 2263 | FGFR2 | umls:C0220658 | BeFree | Gene analysis of these patients showed a T341P mutation in the FGFR2 gene in the patient with Pfeiffer syndrome, and a G380R mutation in the FGFR3 gene in the patient with achondroplasia. | 0.331867498 | 1998 | FGFR3 | 4 | 1804392 | G | A,C |
rs4647924 | 14613973 | 2263 | FGFR2 | umls:C0220658 | BeFree | However, unlike the Apert syndrome Pro253Arg FGFR2c mutant, neither the Pfeiffer syndrome Pro250Arg FGFR1c mutant nor the Muenke syndrome Pro250Arg FGFR3c mutant bound appreciably to FGF7 or FGF10. | 0.331867498 | 2004 | FGFR3 | 4 | 1801844 | C | G |
rs4647924 | 14613973 | 2261 | FGFR3 | umls:C0220658 | BeFree | However, unlike the Apert syndrome Pro253Arg FGFR2c mutant, neither the Pfeiffer syndrome Pro250Arg FGFR1c mutant nor the Muenke syndrome Pro250Arg FGFR3c mutant bound appreciably to FGF7 or FGF10. | 0.001085767 | 2004 | FGFR3 | 4 | 1801844 | C | G |
rs77543610 | 14613973 | 2263 | FGFR2 | umls:C0220658 | BeFree | However, unlike the Apert syndrome Pro253Arg FGFR2c mutant, neither the Pfeiffer syndrome Pro250Arg FGFR1c mutant nor the Muenke syndrome Pro250Arg FGFR3c mutant bound appreciably to FGF7 or FGF10. | 0.331867498 | 2004 | FGFR2 | 10 | 121520160 | G | C |
rs77543610 | 14613973 | 2261 | FGFR3 | umls:C0220658 | BeFree | However, unlike the Apert syndrome Pro253Arg FGFR2c mutant, neither the Pfeiffer syndrome Pro250Arg FGFR1c mutant nor the Muenke syndrome Pro250Arg FGFR3c mutant bound appreciably to FGF7 or FGF10. | 0.001085767 | 2004 | FGFR2 | 10 | 121520160 | G | C |
rs77543610 | 10329600 | 2263 | FGFR2 | umls:C0220658 | BeFree | We analyzed cell proliferation and differentiation in osteoblasts obtained from patients with three genetically and clinically distinct craniosynostoses: Pfeiffer syndrome carrying the FGFR2 C342R substitution, Apert syndrome with FGFR2 P253R change, and a nonsyndromic craniosynostosis without FGFR canonic mutations, as compared with control osteoblasts. | 0.331867498 | 1999 | FGFR2 | 10 | 121520160 | G | C |
rs77543610 | 11596961 | 2260 | FGFR1 | umls:C0220658 | BeFree | In this paper the expression of FGFR1, the IgIIIa/c and IgIIIa/b isoforms of FGFR2, and FGFR3 is investigated in Apert syndrome (P253R mutation)- and Pfeiffer syndrome (C278F mutation)-affected fetal cranial tissue and is contrasted with healthy human control tissues. | 0.20434307 | 2001 | FGFR2 | 10 | 121520160 | G | C |
rs77543610 | 11596961 | 2261 | FGFR3 | umls:C0220658 | BeFree | In this paper the expression of FGFR1, the IgIIIa/c and IgIIIa/b isoforms of FGFR2, and FGFR3 is investigated in Apert syndrome (P253R mutation)- and Pfeiffer syndrome (C278F mutation)-affected fetal cranial tissue and is contrasted with healthy human control tissues. | 0.001085767 | 2001 | FGFR2 | 10 | 121520160 | G | C |
GWASdb Annotation(Total Genotypes:7) | |||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chr | Pos | SNP_Id | RefGene | EnsemblGene | ENCODE_Factor | ENCODE_TFBS | Chromosome_interaction | GTEx_eQTL | SNP_TFBS_affinity_GWAS3D | SNP_miRNA_target_affinity_PolymiRTS | SNP_splicing_effect_Skippy | SNP_splicing_effect_MutPred_Splice | SNP_ns_protein_effect_dbNSFP | SNP_syn_effect_Silva | SNP_phosphorylation_effect_PhosSNP | PhastCons_score | PhyloP_score | GERP++_RS | Segway_state | Ancestral_allele | ESP_AF | ESP_AFR | ESP_AFR | ESP_EUR | TG_ASN | TG_AMR | TG_AFR | TG_EUR | Type | Consequence | bStatistic | EncH3K27Ac | EncH3K4Me1 | EncH3K4Me3 | EncNucleo | OMIM | Clinvar |
10 | 114148689 | rs12255316 | NM_203379,ACSL5 | NM_203380,ACSL5 | NM_016234,ACSL5 | ENST00000354655,ENSG00000197142 | ENST00000479936,ENSG00000197142 | ENST00000393081,ENSG00000197142 | ENST00000369410,ENSG00000197142 | ENST00000433418,ENSG00000197142 | ENST00000356116,ENSG00000197142 | ENST00000354273,ENSG00000197142 | CHMM | TFP.HNF4A | NA | chr10,114140001,114150000,chr10,114010001,114020000,28,Hi-C | chr10,114140001,114150000,chr10,114170001,114180000,5,Hi-C | NA | NA | NA | NA | NA | NA | NA | NA | 0.001 | -0.204 | -0.948 | H3K9me1 | C | NA | NA | NA | NA | NA | NA | NA |
10 | 114150782 | rs7904386 | NM_203379,ACSL5 | NM_203380,ACSL5 | NM_016234,ACSL5 | ENST00000354655,ENSG00000197142 | ENST00000479936,ENSG00000197142 | ENST00000393081,ENSG00000197142 | ENST00000369410,ENSG00000197142 | ENST00000433418,ENSG00000197142 | ENST00000356116,ENSG00000197142 | ENST00000354273,ENSG00000197142 | NA | NA | chr10,114150001,114160000,chr16,32370001,32380000,4,Hi-C | chr10,114150001,114160000,chr18,19370001,19380000,6,Hi-C | NA | LM157,23.5125 | LM202,1.4602 | FOXC1,6.8945 | GATA3,1.3097 | SP1,1.7372 | NA | NA | NA | NA | NA | NA | 0.000 | -2.009 | -5.71 | F0 | T | NA | NA | NA | NA |
10 | 114159452 | rs10885343 | NM_203379,ACSL5 | NM_203380,ACSL5 | NM_016234,ACSL5 | ENST00000354655,ENSG00000197142 | ENST00000479936,ENSG00000197142 | ENST00000393081,ENSG00000197142 | ENST00000369410,ENSG00000197142 | ENST00000433418,ENSG00000197142 | ENST00000356116,ENSG00000197142 | ENST00000354273,ENSG00000197142 | NA | NA | chr10,114150001,114160000,chr16,32370001,32380000,4,Hi-C | chr10,114150001,114160000,chr18,19370001,19380000,6,Hi-C | NA | LM3,2.1697 | LM59,3.1499 | LM196,13.0171 | LM214,2.2175 | FOXC1,1.9645 | NA | NA | NA | NA | NA | NA | 0.000 | -2.072 | -7.39 | F1 | G | NA | NA | NA | 0.470 |
10 | 114159812 | rs4351741 | NM_203379,ACSL5 | NM_203380,ACSL5 | NM_016234,ACSL5 | ENST00000354655,ENSG00000197142 | ENST00000479936,ENSG00000197142 | ENST00000393081,ENSG00000197142 | ENST00000369410,ENSG00000197142 | ENST00000433418,ENSG00000197142 | ENST00000356116,ENSG00000197142 | ENST00000354273,ENSG00000197142 | NA | NA | chr10,114150001,114160000,chr16,32370001,32380000,4,Hi-C | chr10,114150001,114160000,chr18,19370001,19380000,6,Hi-C | NA | LM4,4.7785 | LM16,1.7177 | LM47,1.3849 | LM154,1.4513 | LM213,1.2718 | NA | NA | NA | NA | NA | NA | 0.000 | -0.351 | -1.64 | F0 | C | NA | NA | NA | NA |
10 | 114164146 | rs11195949 | NM_203379,ACSL5 | NM_203380,ACSL5 | NM_016234,ACSL5 | ENST00000354655,ENSG00000197142 | ENST00000479936,ENSG00000197142 | ENST00000393081,ENSG00000197142 | ENST00000369410,ENSG00000197142 | ENST00000433418,ENSG00000197142 | ENST00000356116,ENSG00000197142 | ENST00000354273,ENSG00000197142 | NA | NA | NA | NA | Sfl1-DBD-primary,3.1388 | Smp1-primary,50.8045 | Ypr015c-primary,1.8994 | LM70,1.6596 | LM82,3.5667 | NA | NA | NA | NA | NA | NA | 0.637 | 0.146 | 0.32 | R0 | G | NA | NA | NA | NA | NA |
10 | 114169552 | rs7919710 | NM_203379,ACSL5 | NM_203380,ACSL5 | NM_016234,ACSL5 | ENST00000354655,ENSG00000197142 | ENST00000393081,ENSG00000197142 | ENST00000369410,ENSG00000197142 | ENST00000433418,ENSG00000197142 | ENST00000356116,ENSG00000197142 | ENST00000354273,ENSG00000197142 | ENST00000449782,ENSG00000232934 | ENST00000495539,ENSG00000197142 | NA | NA | NA | NA | Cbf1-primary,18.8424 | Cbf1-primary,19.2217 | Ceh-22,1.2881 | Gsm1-FL-primary,1.4696 | Mbp1-primary,1.4409 | NA | NA | NA | NA | NA | NA | 0.000 | -0.306 | -3.2 | L1 | G | NA | NA | NA | 0.350 |
10 | 114169664 | rs7904918 | NM_203379,ACSL5 | NM_203380,ACSL5 | NM_016234,ACSL5 | ENST00000354655,ENSG00000197142 | ENST00000393081,ENSG00000197142 | ENST00000369410,ENSG00000197142 | ENST00000433418,ENSG00000197142 | ENST00000356116,ENSG00000197142 | ENST00000354273,ENSG00000197142 | ENST00000449782,ENSG00000232934 | ENST00000495539,ENSG00000197142 | MCV-3 | NA | NA | NA | Bapx1_2343,24.1859 | Ceh-22,3.0782 | Nkx2-5_3436,2.1486 | Nkx2-6_3437,9.2865 | Obox1_3970,1.343 | NA | NA | NA | NA | NA | NA | 0.003 | 0.016 | -0.641 | L1 | T | NA | NA | NA | NA |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |